Speakers 2015

-
How to optimize current therapy of G1 patients (chairman) - Monday, January 12th 2015 - 09:00 - 10:00
-
Future therapeutic strategies with direct acting antivirals (chairman) - Tuesday, January 13th 2015 - Lunch Workshops - Room 241
Presentation
-
ALAHDAB Yesim
Turkey
-
- Friday, August 28th 2015 -
-
W2 - Saturday, August 29th 2015 -
Presentation
-
ARROYO Vicente
Spain
-
Acute-on-chronic liver failure is a new clinical entity - Tuesday, January 13th 2015 - 15:00
Presentation
-
-
State of the art lecture (chairman) - Monday, January 12th 2015 - 08:40 - 09:00
-
INF-free therapy in naïve patients - Monday, January 12th 2015 - 16:00
-
State of the art lecture (chairman) - Tuesday, January 13th 2015 - 12:00 - 12:30
-
How to optimize treatment in G4 patients? (chairman) - Tuesday, January 13th 2015 - Lunch Workshops - Room 253
-
Take home message - Tuesday, January 13th 2015 - 16:30
Presentation
-
-
Staging of fibrosis: liver biopsy or indirect markers? (chairman) - Monday, January 12th 2015 - Lunch Workshops - Room 242A
-
Cirrhosis reversibility: who and why? - Tuesday, January 13th 2015 - 08:40
Presentation
-
-
Faut-il traiter les immunotolérants et les porteurs inactifs ? (French speaking lunch workshop) (chairman) - Monday, January 12th 2015 - Lunch Workshops - Room 243
Presentation
-
BENHAMOU Yves
France
-
Future therapeutic strategies with direct acting antivirals (chairman) - Tuesday, January 13th 2015 - Lunch Workshops - Room 241
Presentation
BERG Thomas
Germany
View more View moreBOYER Nathalie
France
-
Faut-il traiter les immunotolérants et les porteurs inactifs ? (French speaking lunch workshop) (chairman) - Monday, January 12th 2015 - Lunch Workshops - Room 243
Presentation
-
-
Traitements des patients rechuteurs et non répondeurs (French speaking lunch workshop) (chairman) - Tuesday, January 13th 2015 - Lunch Workshops - Room 242B
Presentation
-
View more-
Special populations (chairman) - Monday, January 12th 2015 - 14:30 - 15:35
Presentation
-
-
Faut-il traiter les immunotolérants et les porteurs inactifs ? (French speaking lunch workshop) (chairman) - Monday, January 12th 2015 - Lunch Workshops - Room 243
Presentation
-
CALVARUSO Vincenza
Italy
View more-
The control of HBV related liver disease (chairman) - Tuesday, January 13th 2015 - 08:40 - 10:00
Presentation
-
-
Can we predict HCC in chronic viral hepatitis? - Friday, August 28th 2015 - 09:00-09:30
-
How to improve access to therapy? (chairman) - Monday, January 12th 2015 - 11:20 - 12:30
-
Management of hepatocellular carcinoma in 2015 - Tuesday, January 13th 2015 - 15:20
Presentation
-
-
Treatment of hepatitis C today and tomorrow - Monday, January 12th 2015 -
-
How to optimize treatment in G1 naive patients? (chairman) - Tuesday, January 13th 2015 - Lunch Workshops - Room 242A
Presentation
-
-
- Monday, January 12th 2015 -
-
Staging of fibrosis: liver biopsy or indirect markers? (chairman) - Monday, January 12th 2015 - Lunch Workshops - Room 242A
Presentation
-
DEBZI Nabil
Algeria
-
Comment optimiser le traitement des malades naïfs ? (French speaking lunch workshop) (chairman) - Tuesday, January 13th 2015 - Lunch Workshops - Room 243
Presentation
-
-
Comment optimiser le traitement des malades naïfs ? (French speaking lunch workshop) (chairman) - Tuesday, January 13th 2015 - Lunch Workshops - Room 243
Presentation
-
DI BISCEGLIE Adrian
USA
-
End-stage liver disease is a multifaceted condition (chairman) - Tuesday, January 13th 2015 - 15:00 - 16:30
Presentation
-
DURAND François
France
-
Special populations (chairman) - Monday, January 12th 2015 - 14:30 - 15:35
Presentation
-
DUSHEIKO Geoffrey
UK
-
Antiviral treatment in HCV cirrhotic patients on waiting list - Friday, August 28th 2015 -
-
Hepatitis C: new challenges in the era of DAAs (chairman) - Saturday, August 29th 2015 - 10:30-10:45
Presentation
-
-
- Monday, January 12th 2015 -
-
How to optimize treatment in G4 patients? (chairman) - Tuesday, January 13th 2015 - Lunch Workshops - Room 253
Presentation
-
-
- Monday, January 12th 2015 -
-
First line therapy of hepatitis B: interferon or analogues? (chairman) - Monday, January 12th 2015 - Lunch Workshops - Room 241
Presentation
-
ESTRABAUD Emilie
France
-
HCV eradication with DAAs? (chairman) - Tuesday, January 13th 2015 - Lunch Workshops - Room 251
Presentation
-
-
How to manage relapsers and non-responders to PEG IFN + RBV therapy (chairman) - Tuesday, January 13th 2015 - Lunch Workshops - Room 252B
Presentation
-
FERRARI Carlo
Italy
View more-
Access to treatment and disease burden - Saturday, August 29th 2015 -
-
- Monday, January 12th 2015 -
Presentation
-
View more-
How to improve access to therapy? (chairman) - Monday, January 12th 2015 - 11:20 - 12:30
-
HCV eradication with DAAs? (chairman) - Tuesday, January 13th 2015 - Lunch Workshops - Room 251
Presentation
-
-
Optimal therapy of chronic hepatitis B (chairman) - Tuesday, January 13th 2015 - 10:30 - 12:00
Presentation
-
GOVAERE Olivier
Belgium
View more-
Clinical applications of HBsAg quantification (chairman) - Monday, January 12th 2015 - Lunch Workshops - Room 242B
Presentation
-
-
Traitements des patients rechuteurs et non répondeurs (French speaking lunch workshop) (chairman) - Tuesday, January 13th 2015 - Lunch Workshops - Room 242B
Presentation
-
HORBAN Andrzej
Poland
-
How to manage relapsers and non-responders to PEG IFN + RBV therapy (chairman) - Tuesday, January 13th 2015 - Lunch Workshops - Room 252B
Presentation
-
-
Workshop 1: Non invasive methods for fibrosis in the management of cirrhosis (chairman) - Friday, August 28th 2015 -
-
- Monday, January 12th 2015 -
Presentation
-
-
New therapeutic strategies (chairman) - Monday, January 12th 2015 - 16:00 - 16:50
Presentation
-
JALAN Rajiv
UK
-
Treatment of HCV cirrhosis and transplanted patients (chairman) - Monday, January 12th 2015 - Lunch Workshops - Room 252B
Presentation
-
-
PEG IFN based therapy with 2nd wave DAAs - Monday, January 12th 2015 - 09:00
-
Triple therapy with telaprevir or boceprevir: management of side effects (chairman) - Tuesday, January 13th 2015 - Lunch Workshops - Room 252A
Presentation
-
-
Optimal therapy of chronic hepatitis B (chairman) - Tuesday, January 13th 2015 - 10:30 - 12:00
Presentation
-
-
The long term impact of treatment on the outcome of liver disease (chairman) - Monday, January 12th 2015 - Lunch Workshops - Room 253
-
What have we learned from HBV clinical cohorts? - Tuesday, January 13th 2015 - 09:10
Presentation
-
KARAGINANNAKIS Dimitrios
Greece
View moreKILANI Badreddine
Tunisia
-
Traitements des patients rechuteurs et non répondeurs (French speaking lunch workshop) (chairman) - Tuesday, January 13th 2015 - Lunch Workshops - Room 242B
Presentation
-
KOUCHNER Bernard
France
-
Hepatitis C: A public health priority - Monday, January 12th 2015 - 17:25
Presentation
-
View moreLARSSON Simon
Sweden
-
Workshop 3: The role of Pegylated IFN in HBV therapy (chairman) - Friday, August 28th 2015 -
-
W3 - Saturday, August 29th 2015 -
Presentation
-
LEQUOY Marie
France
View moreLEROY Vincent
France
-
Traitements des patients rechuteurs et non répondeurs (French speaking lunch workshop) (chairman) - Tuesday, January 13th 2015 - Lunch Workshops - Room 242B
Presentation
-
-
Short presentations (chairman) - Friday, August 28th 2015 - 11:00-12:30
-
HCV eradication with DAAs? (chairman) - Tuesday, January 13th 2015 - Lunch Workshops - Room 251
Presentation
-
-
How to optimize current therapy of non G1 patients (chairman) - Monday, January 12th 2015 - 10:20 - 11:20
Presentation
-
LOANNIDOU Panagiota
Greece
-
- Friday, August 28th 2015 -
-
W4 - Saturday, August 29th 2015 -
Presentation
-
MANNS Michael
Germany
-
- Monday, January 12th 2015 -
-
New therapeutic strategies (chairman) - Monday, January 12th 2015 - 16:00 - 16:50
Presentation
-
-
Restitution of workshops (chairman) - Saturday, August 29th 2015 - 09:00-10:00
-
Awards and Conclusion - Saturday, August 29th 2015 - 11:45-12:00
-
Introduction: Treatment of hepatitis C: towards the eradication? - Monday, January 12th 2015 - 08:30
-
How to improve access to therapy? (chairman) - Monday, January 12th 2015 - 11:20 - 12:30
-
Introduction: is HBV controlled? - Tuesday, January 13th 2015 - 08:30
-
State of the art lecture and Award (chairman) - Tuesday, January 13th 2015 - 14:30 - 15:00
Presentation
-
Clinical applications of HBsAg quantification (chairman) - Monday, January 12th 2015 - Lunch Workshops - Room 242B
-
HBsAg quantification to manage patients - Tuesday, January 13th 2015 - 08:55
Presentation
-
MATHURIN Philippe
France
-
Comment optimiser le traitement des malades naïfs ? (French speaking lunch workshop) (chairman) - Tuesday, January 13th 2015 - Lunch Workshops - Room 243
Presentation
-
MEHTA Gautam
UK
-
- Friday, August 28th 2015 -
-
W2 - Saturday, August 29th 2015 -
Presentation
-
MINDRUT Eugenia
Romania
-
- Friday, August 28th 2015 -
-
W4 - Saturday, August 29th 2015 -
Presentation
-
-
End-stage liver disease is a multifaceted condition (chairman) - Tuesday, January 13th 2015 - 15:00 - 16:30
Presentation
-
MORENO Christophe
Belgium
-
Controversies in the management of cirrhosis (chairman) - Friday, August 28th 2015 - 09:30-10:30
-
Workshop 2: Management of acute alcoholic hepatitis (chairman) - Friday, August 28th 2015 -
Presentation
-
MOROZOV Sergey
Russia
-
Workshop 3: The role of Pegylated IFN in HBV therapy (chairman) - Friday, August 28th 2015 -
-
W3 - Saturday, August 29th 2015 -
Presentation
-
NEGRO Francesco
Switzerland
-
Short presentations (chairman) - Friday, August 28th 2015 - 11:00-12:30
Presentation
-
View more-
Interferon ou analogue ? (French speaking lunch workshop) (chairman) - Monday, January 12th 2015 - Lunch Workshops - Room 252A
Presentation
-
PAIS Raluca
France
-
How to optimize treatment in G1 naive patients? (chairman) - Tuesday, January 13th 2015 - Lunch Workshops - Room 242A
Presentation
-
View more-
- Monday, January 12th 2015 -
Presentation
-
PARFIENUIK-KOWERDA Anna
Poland
View more-
Triple therapy with telaprevir or boceprevir: management of side effects (chairman) - Tuesday, January 13th 2015 - Lunch Workshops - Room 252A
Presentation
-
PERALVAREZ Manuel Rodriguez
Spain
-
- Friday, August 28th 2015 -
-
W1 - Saturday, August 29th 2015 -
Presentation
-
PETERSEN Jorg
Germany
View more-
Workshop 4: Severe liver diseases in HIV patients (chairman) - Friday, August 28th 2015 -
-
Hepatitis C: new challenges in the era of DAAs (chairman) - Saturday, August 29th 2015 - 10:30-10:45
-
How to optimize current therapy of G1 patients (chairman) - Monday, January 12th 2015 - 09:00 - 10:00
Presentation
-
-
Faut-il traiter les immunotolérants et les porteurs inactifs ? (French speaking lunch workshop) (chairman) - Monday, January 12th 2015 - Lunch Workshops - Room 243
Presentation
-
PUNETE SANCHEZ Ángela
Spain
-
Beta blockers in cirrhosis - Friday, August 28th 2015 -
Presentation
-
RADASAN Andreea
Romania
-
- Friday, August 28th 2015 -
-
W1 - Saturday, August 29th 2015 -
Presentation
-
RATZIU Vlad
France
-
How to optimize treatment in G1 naive patients? (chairman) - Tuesday, January 13th 2015 - Lunch Workshops - Room 242A
Presentation
-
ROCKSTROH Juergen
Germany
-
HIV-HCV coinfections (chairman) - Monday, January 12th 2015 - Lunch Workshops - Room 251
-
HIV co-infected patients - Monday, January 12th 2015 - 15:00
Presentation
-
-
Controversies in the management of cirrhosis (chairman) - Friday, August 28th 2015 - 09:30-10:30
-
Workshop 1: Non invasive methods for fibrosis in the management of cirrhosis (chairman) - Friday, August 28th 2015 -
-
Treatment of HCV cirrhosis and transplanted patients (chairman) - Monday, January 12th 2015 - Lunch Workshops - Room 252B
-
DAAs and transplant patients - Monday, January 12th 2015 - 14:45
Presentation
-
-
Controversy: Cure of HCV-related liver disease? (chairman) - Monday, January 12th 2015 - 16:50 - 17:25
-
Viral hepatitis: the past and the future - Tuesday, January 13th 2015 - 14:30
Presentation
-
-
Workshop 2: Management of acute alcoholic hepatitis (chairman) - Friday, August 28th 2015 -
-
Patients monitoring after SVR - Saturday, August 29th 2015 -
-
Awards and Conclusion - Saturday, August 29th 2015 - 11:45-12:00
-
Predictors of response to IFN-based therapy - Monday, January 12th 2015 - 09:30
Presentation
-
View moreSOGNI Philippe
France
-
Clinical applications of HBsAg quantification (chairman) - Monday, January 12th 2015 - Lunch Workshops - Room 242B
Presentation
-
STREINU-CERCEL Anca
Romania
-
How to optimize treatment in G1 naive patients? (chairman) - Tuesday, January 13th 2015 - Lunch Workshops - Room 242A
Presentation
-
-
HIV-HCV coinfections (chairman) - Monday, January 12th 2015 - Lunch Workshops - Room 251
Presentation
-
TOMASIEWICZ Krzysztof
Poland
-
Antiviral treatment in HCV cirrhotic patients on waiting list - Friday, August 28th 2015 -
Presentation
-
TOZUN Nurdan
Turkey
-
Workshop 4: Severe liver diseases in HIV patients (chairman) - Friday, August 28th 2015 -
-
The long term impact of treatment on the outcome of liver disease (chairman) - Monday, January 12th 2015 - Lunch Workshops - Room 253
Presentation
-
-
Interferon ou analogue ? (French speaking lunch workshop) (chairman) - Monday, January 12th 2015 - Lunch Workshops - Room 252A
Presentation
-
TREPO Eric
France
-
Beta blockers in cirrhosis - Friday, August 28th 2015 -
Presentation
-
URBANEK Petr
Czech Republic
-
Triple therapy with telaprevir or boceprevir: management of side effects (chairman) - Tuesday, January 13th 2015 - Lunch Workshops - Room 252A
Presentation
-
VALLA Dominique
France
-
Treatment of HCV cirrhosis and transplanted patients (chairman) - Monday, January 12th 2015 - Lunch Workshops - Room 252B
-
The coagulation system in end-stage liver disease - Tuesday, January 13th 2015 - 15:40
Presentation
-
-
Restitution of workshops (chairman) - Saturday, August 29th 2015 - 09:00-10:00
-
Comment optimiser le traitement des malades naïfs ? (French speaking lunch workshop) (chairman) - Tuesday, January 13th 2015 - Lunch Workshops - Room 243
Presentation
-
View moreWEILAND Ola
Sweden
View moreYURDAYDIN Cihan
Turkey
-
First line therapy of hepatitis B: interferon or analogues? (chairman) - Monday, January 12th 2015 - Lunch Workshops - Room 241
Presentation
-
-
Interferon ou analogue ? (French speaking lunch workshop) (chairman) - Monday, January 12th 2015 - Lunch Workshops - Room 252A
Presentation
-
ZEUZEM Stefan
Germany
-
How to optimize current therapy of non G1 patients (chairman) - Monday, January 12th 2015 - 10:20 - 11:20
Presentation
-
-
How to manage relapsers and non-responders to PEG IFN + RBV therapy (chairman) - Tuesday, January 13th 2015 - Lunch Workshops - Room 252B
Presentation
-
ZOULIM Fabien
France
-
The control of HBV related liver disease (chairman) - Tuesday, January 13th 2015 - 08:40 - 10:00
Presentation
-